Evidence map›Paper›PMID 40595542›Full record

ArticleNature communications2025

An ex vivo uterine system captures implantation, embryogenesis, and trophoblast invasion via maternal-embryonic signaling.

Takehiro Hiraoka, Shizu Aikawa, Daisuke Mashiko, Tatsuya Nakagawa, Hiroki Shirai, Yasushi Hirota, Hiroshi Kimura, Masahito Ikawa

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Takehiro HiraokaResearch Institute for Microbial Diseases, Osaka University, Osaka, Japan. t_hiraoka1985@yahoo.co.jp.ORCID http://orcid.org/0009-0006-4030-3278
Shizu AikawaDepartment of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0001-7407-4051
Daisuke MashikoResearch Institute for Microbial Diseases, Osaka University, Osaka, Japan.ORCID http://orcid.org/0000-0003-3927-3076
Tatsuya NakagawaResearch Institute for Microbial Diseases, Osaka University, Osaka, Japan.ORCID http://orcid.org/0009-0002-0418-4030
Hiroki ShiraiMicro/Nano Technology Center, Tokai University, Kanagawa, Japan.
Yasushi HirotaDepartment of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-0241-9780
Hiroshi KimuraMicro/Nano Technology Center, Tokai University, Kanagawa, Japan.ORCID http://orcid.org/0000-0003-0623-0248
Masahito IkawaResearch Institute for Microbial Diseases, Osaka University, Osaka, Japan. ikawa@biken.osaka-u.ac.jp.ORCID http://orcid.org/0000-0001-9859-6217

Funding

Japan Agency for Medical Research and Development (AMED) JP23jf0126001MEXT | Japan Science and Technology Agency (JST) JPMJCR21N1MEXT | Japan Society for the Promotion of Science (JSPS) JP21H05033, JP22H04922, JP23K20043
6 · The paper itself

Abstract

Embryo implantation remains challenging to study because of its inaccessibility in situ despite its essentiality and clinical significance. Although recent studies on long-term culture of authentic and model embryos have provided significant advances in elucidating embryogenesis in vitro, they, without the uterus, cannot genuinely replicate implantation. Here, we have recapitulated bona fide implantation ex vivo at more than 90% efficiency followed by embryogenesis and trophoblast invasion using authentic mouse embryos and uterine tissue. We utilized air-liquid interface culture method with originally developed devices manufactured with polydimethylsiloxane. Notably, the system replicated the robust induction of a maternal implantation regulator COX-2 at the attachment interface, which was accompanied by trophoblastic AKT activation, suggesting a possible signaling that mediates maternal COX-2 and embryonic AKT1 that accelerates implantation. By expanding the ex vivo findings, embryonic AKT1 transduction ameliorated defective implantation of uterine origin by a COX-2 inhibitor in vivo. The system, proposing a potentially standard platform of embryogenesis, offers a concise, reproducible, and scalable screening system, suggesting significant implications for developmental biology and therapeutic strategies for recurrent implantation failure in assisted reproductive technology.

Indexed as

Embryo ImplantationEmbryonic DevelopmentTrophoblastsUterusAnimalsCyclooxygenase 2Embryo, MammalianFemaleMicePregnancyProto-Oncogene Proteins c-aktSignal TransductionAkt1 protein, mouseCyclooxygenase 2Proto-Oncogene Proteins c-aktPtgs2 protein, mouse

Identifiers

PMID40595542
PMCPMC12217791

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.